Biogen وBeckman Coulter وFujirebio يتوصلون إلى صيغة تعاون في مجال المؤشرات الحيوية القائمة على الدم واختبار الاعتلال الخاص ببروتين تاو في مرض الزهايمر Tem 31, 2024 System Admin Healthcare
Healthcare model development' committee explores new initiatives, programmes Tem 31, 2024 Beatriz Escanilla Healthcare
Biogen, Beckman Coulter and Fujirebio to Collaborate on Blood-Based Biomarkers and Test for Tau Pathology in Alzheimer’s Disease Tem 30, 2024 System Admin Healthcare
Galderma’s Relfydess™ (RelabotulinumtoxinA) Receives Positive Decision for Use in Europe Tem 30, 2024 System Admin Healthcare
اختبار الدم Guardant Health's Shield™ الذي وافقت عليه إدارة الأغذية والعقاقير (FDA) كخيار فحص أولي، يمهّد الطريق أمام تعويضات الرعاية الطبية وبداية عص Tem 30, 2024 System Admin Healthcare
Guardant Health’s Shield™ Blood Test Approved by FDA as a Primary Screening Option, Clearing Path for Medicare Reimbursement and a New Era of Colorectal Cancer Screening Tem 29, 2024 System Admin Healthcare
WCM-Q hosts global congress on precision health innovations Tem 29, 2024 Beatriz Escanilla Healthcare
